CYRX - クリオポ―ト （CryoPort Inc.）

Cryoport has significantly underperformed the broader market over the past several months. See why I think a sell rating is appropriate for CYRX stock.

Cryoport has been punished over the last 12 months amid a number of downside catalysts. Click here to read why we rate CYRX stock a Buy.

Partnership to Provide Cell and Gene Industry Integrated Solution including Cryoport''s IntegriCell™ platform, and Supply Chain Services NASHVILLE, Tenn., Jan. 18, 2023 /PRNewswire/ -- Cryoport, Inc. (NASDAQ: CYRX) ("Cryoport"), a leading global provider of innovative…

Cryoport Inc. (NASDAQ:CYRX)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.22. At the close of trading, the stock’s price was $16.40, to imply a decrease of -4.76% or -$0.82 in intraday trading. The CYRX share’s 52-week high remains $60.36, putting it -268.05% down since that peak … Stock Of Cryoport Inc. (NASDAQ: CYRX) Dropped By -13.55 Percent Over The Past Month, Is There Room For Downside? Read More »

NASHVILLE, Tenn., Dec. 20, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that Jerrell Shelton, the Company''s Chief Executive Officer, will…

Cryoport Inc. (NASDAQ:CYRX)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.22. At the close of trading, the stock’s price was $16.40, to imply a decrease of -4.76% or -$0.82 in intraday trading. The CYRX share’s 52-week high remains $60.36, putting it -268.05% down since that peak … Stock Of Cryoport Inc. (NASDAQ: CYRX) Dropped By -13.55 Percent Over The Past Month, Is There Room For Downside? Read More »

NASHVILLE, Tenn., Dec. 20, 2022 /PRNewswire/ -- Cryoport, Inc. (Nasdaq: CYRX) ("Cryoport" or the "Company"), a global leader in temperature-controlled supply chain solutions for the life sciences industry, today announced that Jerrell Shelton, the Company''s Chief Executive Officer, will…

https://www.investing.com/news/pro/cryoport-pt-lowered-to-30-at-keybanc-432SI-2959705

Cryoport Inc. (NASDAQ:CYRX)’s traded shares stood at 0.3 million during the last session, with the company’s beta value hitting 1.24. At the close of trading, the stock’s price was $19.99, to imply an increase of 0.55% or $0.11 in intraday trading. The CYRX share’s 52-week high remains $70.90, putting it -254.68% down since that peak … Cryoport Inc. (NASDAQ: CYRX) Shares Fall By 6.05 Percent In The Past Week, But How Long Will It Last? Read More »

Despite macroeconomic concerns, Cryoport is still generating a 7% revenue growth for the quarter. Learn why I maintain my buy recommendation on Cryoport with a 5/5 stars rating.

Cryoport (CYRX) on Wednesday said its New Prague facility returned to full production.A fire occurred in a portion of the CYRX unit MVE Biological Solutions manufacturing facility in…

Cryoport''s (CYRX) board has unanimously authorized a repurchase program, under which Cryoport may repurchase up to $100M of its outstanding common stock and/or convertible senior…

CryoPort Inc''s (NASDAQ: CYRX ) Board has authorized a repurchase program . Per the program, CryoPort may repurchase up to $100 million of its outstanding common stock and/or convertible senior notes. The repurchase program … Full story available on Benzinga.com